文献速递创伤与烧伤复苏、休克与脓毒症

创伤大出血患者的经验性输血策略:一项系统评价

Empirical transfusion strategies for major hemorrhage in trauma patients: A systematic review.
PubMed 文献 · J Trauma Acute Care Surg · 2020-01-01
一句话结论系统评价未确定最佳经验性输血方案,但早期使用冷沉淀可能降低死亡率;现有证据样本有限。

这项系统评价检索四个数据库,纳入随机对照试验,比较创伤大出血经验性输血策略,以死亡率和并发症为结局。结果显示,在标准大出血方案中早期给予冷沉淀与较低死亡风险相关,其他策略显示负面影响;血栓栓塞事件、多器官衰竭、脓毒症、住院时间及总输血需求等并发症被评估。分析未确定明确的最佳方案,作者初步建议冷沉淀补充较当前方案死亡率更有利,并因样本量有限建议纳入回顾性/前瞻性队列研究以增强未来综述的统计效能。

要点

  • 在标准大出血方案中早期给予冷沉淀与较低死亡风险相关。
  • 其他经验性输血策略显示对结局有负面影响。
  • 分析未确定明确的最佳经验性输血方案。
  • 作者初步建议冷沉淀补充较当前方案死亡率更有利。
  • 因样本量有限,作者建议纳入回顾性/前瞻性队列研究增强未来综述统计效能。

适用人群与场景

  • 创伤大出血患者

研究设计与关键结果

  • 研究类型为系统评价,检索四个数据库,纳入随机对照试验,使用苏格兰学院间指南网络(SIGN)批准的清单进行双人独立质量评价。
  • 证据提示在标准大出血方案中早期给予冷沉淀与较低死亡风险相关。
  • 其他经验性输血策略显示对结局有负面影响。
  • 评估的并发症包括血栓栓塞事件、多器官衰竭、脓毒症、不同方案启动后住院时间及总输血需求。
  • 分析未确定明确的最佳经验性输血方案。
  • 作者初步建议冷沉淀补充较当前方案死亡率更有利。

证据类型、等级与局限

  • 证据类型:系统评价,证据等级 Level III。
  • 局限:样本量有限(原文 limited sample populations),作者建议纳入回顾性/前瞻性队列研究以增强未来综述的统计效能,直至有足够效能的随机对照试验可用。

对床旁实践的改变

  • 作者初步建议:冷沉淀补充较当前方案死亡率更有利(原文为 preliminary recommendation)。
  • 作者建议:纳入回顾性/前瞻性队列研究以增强未来综述的统计效能,直至有足够效能的随机对照试验可用。

指南或共识出处

  • 当前美国国家卫生与临床优化研究所(NICE)指南建议红细胞与血浆比例为1:1。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Major hemorrhage is a significant cause of mortality and morbidity around the world. There is currently no consensus on the best empirical transfusion strategy. The current National Institute for Clinical Excellence (NICE) guidelines suggest a ratio of 1:1 of red blood cells and plasma. The aim of this study is to compare this to alternative strategies identified through review of the available literature with the objective of identifying the best protocol for mortality outcomes and complication rates.

METHODS: A systematic review of the literature was conducted using four databases. Inclusion and exclusion criteria were applied to produce a suitable list of randomized control trials for review. Critical appraisal of each article was then performed, using a Scottish Intercollegiate Guidelines Network-approved checklist, in duplicate and was subject to further independent scrutiny when required.

RESULTS: Evidence suggests that early administration of cryoprecipitate within the standard practiced major hemorrhage protocol is associated with a lower risk of mortality. Other strategies suggested a negative impact. Complications including incidence of thromboembolic events, multiple organ failure and sepsis as well as length of stay in hospital following activation of the different protocols and overall transfusion requirements were assessed. No clear optimal protocol was identified from our analysis.

CONCLUSION: This project demonstrates that there is no significant clarity regarding morbidity and mortality. As a preliminary recommendation, cryoprecipitate supplementation suggests more favorable mortality over the current protocol. Due to the limited sample populations, we recommend the inclusion of retrospective/prospective cohort studies to bolster the statistical power of any future reviews until randomized control trials of sufficient power are available.

LEVEL OF EVIDENCE: Systematic review, Level III.

来源:J Trauma Acute Care Surg,查看原文。版权归原作者所有。

参考来源

  1. Ritchie DT, Philbrook FGA, Leadbitter S, et al. Empirical transfusion strategies for major hemorrhage in trauma patients: A systematic review. J Trauma Acute Care Surg. 2020. PMID: 32459450. doi:10.1097/TA.0000000000002685

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。